 Practical Knowledge Series - How to Fund Your Company (without giving away your firstborn) When: January 22, 2010 8:30 am Registration/ Continental Breakfast 9:00 am- 11:00 am Presentation, Q&A & Networking Where: Brandywine Trust Realty 401 Plymouth Road 1st Floor Conference Room Plymouth Meeting, PA 19462 OUR EXPERT PANEL: Moderator: J. Todd Abrams, Ph.D. Director, Philanthropy and Business Development Lankenau Institute for Medical Research Panelists: Christopher J. Laing, MRCVS, Ph.D. Director of Science and Technology University City Science Center Reid Leonard, Ph.D. Executive Director Licensing & External Research Merck & Co., Inc. Eric Tweer Senior Vice President, Commercial Banking Citizens Bank ABOUT OUR PROGRAM Many young companies seek non-dilutive funding to preserve equity. Some use the founder’s personal assets and credit cards to get the company started; others seek SBIR grants to support product development. A third option is gaining traction - pharmaceutical companies, looking to de-risk partnering with early stage companies, may provide grants, which contain options but no equity consideration. All of these strategies have pros and cons, and scientific founders and first-time entrepreneurs should understand when and how to use them. We have invited an outstanding panel with specific expertise in these three non-dilutive funding strategies. A bank representative will talk about how to manage secured funds, such as a second mortgage, and unsecured funds, such as credit cards, in order to get your company started. He will also discuss bank and other loan programs to assist the start up company. A grants strategist will talk about the virtues and dangers of SBIR grants, including grant addiction and distraction. A pharmaceutical representative will discuss his company’s non-dilutive funding to de-risk partnerships. Finally, there will be additional discussion of the open source concept in which projects are funded to meet milestones but no licensing agreement or co-development deal is made. At the end of this panel participants should have a greater understanding of: * How to use your credit cards and personal assets to get your company started * When to apply for an SBIR grant * What ingredients increase your chances for funding * When should you forgo a grant * What the new models are with potential partners to obtain non-dilutive funds that can help you de-risk your technology for partnership Event scheduled: Jan 22 2010 |
 |
|||
Nurturing early-stage and emerging life science companies
